IBN
Închide
Selectează perioada
Print PDF

Prezenţa autorilor din străinătate în revista Annals of the Rheumatic Diseases

Afisarea articolelor: 1-15(15)
2019
1. BECKER, M., Spitalul Universitar din Zurich, Elveţia, GRAF, N., Graf Biostatistics, Winterthur, Elveţia, SAUTER, R., Universitatea din Oxford, Marea Britanie, POPA, S., dr., NOI, A. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis. Annals of the Rheumatic Diseases. 2019, nr. , 1248-1242. ISSN - ISSNe 0003-4967.
2. HOUSSIAU, F., Universitatea catolică din Louvain, Belgia, THANOU, A., Oklahoma Medical Research Foundation, Oklahoma City, Statele Unite ale Americii, MAZUR, M., dr.hab, RAMITERRE, E., Centrul Medical al Filipinelor de Sud, Davao, Filipine, GOMEZ MORA, D., Universitatea Națională din Columbia, Zipaquira, Columbia, MISTERSKA-SKORA, M., Centrul Medical Oporow, Wroclaw, Polonia, PERICH-CAMPOS, R., Spitalul Național Guillermo Almenara Irigoyen, Lima, Peru, SMAKOTINA, S., Universitatea de Stat de Medicină din Kemerovo, Rusia, CERPA CRUZ, S., Hospital Civil de Guadalajara 'Fray Antonio Alcalde', Guadalajara, Mexic, LOUZIR, B., Spitalul Militar din Tunis, Tunisia, CROUGHS, T., Neovacs S.A, Paris, Franţa, TEE, M., Universitatea din Filipine Manila, Filipine IFN-α kinoid in systemic lupus erythematosus: Results from a phase IIb, randomised, placebo-controlled study. Annals of the Rheumatic Diseases. 2019, nr. , 0-0. ISSN - ISSNe 0003-4967.
3. PUTRIK, P., Maastricht University, Țările de Jos (Olanda), DESEATNICOVA, E., dr. Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries. Annals of the Rheumatic Diseases. 2019, nr. , 1479-1472. ISSN - ISSNe 0003-4967.
4. WU, W., Spitalul Universitar din Zurich, Elveţia, JORDAN, S., Spitalul Universitar din Zurich, Zurich, Elveţia, GRAF, N., Graf Biostatistics, Winterthur, Elveţia, POPA, S., dr., NOI, A. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort. Annals of the Rheumatic Diseases. 2019, nr. , 656-648. ISSN - ISSNe 0003-4967.
2018
5. GLATT, S., UCB Pharma, Slough, Marea Britanie, BAETEN, D., UCB Pharma, Brussels, Belgia, BAKER, T., UCB Pharma, Slough, Marea Britanie, GRIFFITHS, M., UCB Pharma, Slough, Marea Britanie, IONESCU, L., UCB Pharma, Brussels, Belgia, LAWSON, A., UCB Pharma, Slough, Marea Britanie, MAROOF, A., UCB Pharma, Slough, Marea Britanie, OLIVER, R., UCB Pharma, Slough, Marea Britanie, POPA, S., dr., STRIMENOPOULOU, F., UCB Pharma, Slough, Marea Britanie, VAJJAH, P., UCB Pharma, Slough, Marea Britanie, WATLING, M., UCB Pharma, Slough, Marea Britanie, YEREMENKO, N., Национальный университет физического воспитания и спорта Украины, Ucraina, MIOSSEC, P., Université Lyon, Franţa, SHAW, S., UCB Pharma, Slough, Marea Britanie Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: Evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Annals of the Rheumatic Diseases. 2018, nr. , 532-523. ISSN - ISSNe 0003-4967.
2017
6. KOWAL-BIELECKA, O., Medical University of Bialystok, Polonia, POPA, S., dr., NOI, A. Update of EULAR recommendations for the treatment of systemic sclerosis. Annals of the Rheumatic Diseases. 2017, nr. , 1339-1327. ISSN - ISSNe 0003-4967.
7. WALLACE, D., Centrul Medical Cedars-Sinai, Los Angeles, Statele Unite ale Americii, STRAND, V., Universitatea Stanford, Palo Alto, Statele Unite ale Americii, MERRILL, J., Oklahoma Medical Research Foundation, Oklahoma City, Statele Unite ale Americii, POPA, S., dr., SPINDLER, A., Centrul Medical Privat de Reumatologie, Tucuman, Argentina, EIMON, A., CEMIC, Buenos Aires, Argentina, NOI, A. Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: A phase II dose-ranging randomised controlled trial. Annals of the Rheumatic Diseases. 2017, nr. , 542-534. ISSN - ISSNe 0003-4967.
8. WESTHOVENS, R., Katholieke Universiteit Leuven, Belgia, TAYLOR, P., Universitatea din Oxford, Marea Britanie, ALTEN, R., Schlosspark-Klinik Innere Medizin II, Berlin, Germania, PAVLOVA, D., LTD mandM CENTRS, Adazi, Letonia, ENRIQUEZ-SOSA, F., CLINSTILE, S.A. de C.V, Mexico City, Mexic, MAZUR, M., dr.hab, GREENWALD, M., Desert Medical Advances, Palm Desert, CA, Statele Unite ale Americii, VAN DER AA, A., Galapagos NV, Mechelen, Belgia, VANHOUTTE, F., Galapagos NV, Mechelen, Belgia, TASSET, C., Galapagos NV, Mechelen, Belgia, HARRISON, P., Galapagos NV, Mechelen, Belgia Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: Results from a randomised, dose-finding study (DARWIN 1). Annals of the Rheumatic Diseases. 2017, nr. , 1008-998. ISSN - ISSNe 0003-4967.
2016
9. AVOUAC, J., L'Université Paris Descartes, Franţa, POPA, S., dr., AGACHI, S., dr. Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study. Annals of the Rheumatic Diseases. 2016, nr. , 109-103. ISSN - ISSNe 0003-4967.
2015
10. JORDAN, S., Spitalul Universitar din Zurich, Zurich, Elveţia, DISTLER, J., Friedrich-Alexander University Erlangen-Nuremberg, Germania, MAURER, B., Spitalul Universitar din Zurich, Zurich, Elveţia, NOI, A., POPA, S., dr. Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group. Annals of the Rheumatic Diseases. 2015, nr. , 1194-1188. ISSN - ISSNe 0003-4967.
11. MAURER, B., Spitalul Universitar din Zurich, Zurich, Elveţia, GRAF, N., Graf Biostatistics, Winterthur, Elveţia, MICHEL, B., Spitalul Universitar din Zurich, Elveţia, AGACHI, S., dr., GROPPA, L., dr.hab, CHIABURU, L., NOI, A. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Annals of the Rheumatic Diseases. 2015, nr. , 1131-1124. ISSN - ISSNe 0003-4967.
12. SIVERA, F., Spitalul General Universitario de Elda, Alicante, Spania, RAMIRO, S., Leiden University Medical Center, Țările de Jos (Olanda), CIKES, N., School of Medicine, University of Zagreb, Croaţia, NOI, A., DESEATNICOVA, E., dr. Differences and similarities in rheumatology specialty training programmes across European countries. Annals of the Rheumatic Diseases. 2015, nr. , 1187-1183. ISSN - ISSNe 0003-4967.
2014
13. PUTRIK, P., Maastricht University, Țările de Jos (Olanda), RAMIRO, S., Leiden University Medical Center, Țările de Jos (Olanda), KVIEN, T., Diakonhjemmet Hospital, Norvegia, DESEATNICOVA, E., dr., NOI, A. Inequities in access to biologic and synthetic DMARDs across 46 European countries. Annals of the Rheumatic Diseases. 2014, nr. , 206-198. ISSN - ISSNe 0003-4967.
14. PUTRIK, P., Maastricht University, Țările de Jos (Olanda), RAMIRO, S., Leiden University Medical Center, Țările de Jos (Olanda), KVIEN, T., Diakonhjemmet Hospital, Norvegia, DESEATNICOVA, E., dr., NOI, A. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?. Annals of the Rheumatic Diseases. 2014, nr. , 2021-2010. ISSN - ISSNe 0003-4967.
2011
15. AVOUAC, J., L'Université Paris Descartes, Franţa, FRANSEN, J., Radboud University Nijmegen Medical Centre, Nijmegen, Țările de Jos (Olanda), WALKER, U., Universitatea din Basel, Elveţia, POPA, S., dr., NOI, A. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi consensus study from EULAR scleroderma trials and research group. Annals of the Rheumatic Diseases. 2011, nr. , 0-0. ISSN - ISSNe 0003-4967.
 
 

1-15 of 15